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Objective: To evaluate the discriminatory value and compare the predictive performance of six non-
invasive tests used for perioperative cardiac risk stratification in patients undergoing major vascular
surgery.
Design: Meta-analysis of published reports.
Methods: Eight studies on ambulatory electrocardiography, seven on exercise electrocardiography, eight
on radionuclide ventriculography, 23 on myocardial perfusion scintigraphy, eight on dobutamine stress
echocardiography, and four on dipyridamole stress echocardiography were selected, using a systematic
review of published reports on preoperative non-invasive tests from the Medline database (January 1975
and April 2001). Random effects models were used to calculate weighted sensitivity and specificity from
the published results. Summary receiver operating characteristic (SROC) curve analysis was used to
evaluate and compare the prognostic accuracy of each test. The relative diagnostic odds ratio was used to
study the differences in diagnostic performance of the tests.
Results: In all, 8119 patients participated in the studies selected. Dobutamine stress echocardiography had
the highest weighted sensitivity of 85% (95% confidence interval (CI) 74% to 97%) and a reasonable
specificity of 70% (95% CI 62% to 79%) for predicting perioperative cardiac death and non-fatal
myocardial infarction. On SROC analysis, there was a trend for dobutamine stress echocardiography to
perform better than the other tests, but this only reached significance against myocardial perfusion
scintigraphy (relative diagnostic odds ratio 5.5, 95% CI 2.0 to 14.9).
Conclusions: On meta-analysis of six non-invasive tests, dobutamine stress echocardiography showed a
positive trend towards better diagnostic performance than the other tests, but this was only significant in
the comparison with myocardial perfusion scintigraphy. However, dobutamine stress echocardiography
may be the favoured test in situations where there is valvar or left ventricular dysfunction.
P
atients undergoing major vascular surgery are at
increased risk for cardiovascular complications such as
cardiac death and non-fatal myocardial infarction
because of underlying coronary artery disease.1 These
complications may occur during or directly after surgery.
The aim of preoperative evaluation is to identify patients with
significant coronary artery disease who are thus at increased
risk of cardiac complications. Appropriate patient manage-
ment would then include strategies to reduce this risk.
The identification of clinical risk factors and the role of
non-invasive diagnostic testing to predict perioperative
cardiac risk have been evaluated over recent decades. These
have included multifactorial clinical scoring systems2–4 based
on non-invasive tests such as ambulatory electrocardiogra-
phy,5–12 exercise electrocardiography,13–19 radionuclide ventri-
culography,20–27 and myocardial perfusion scintigraphy.10 28–49
It has been suggested that the most accurate information
about the individual patient risk profile can be obtained by
adding clinical characteristics to those obtained by myocar-
dial perfusion scintigraphy.33 Recently, the use of pharmaco-
logical stress echocardiography with either dipyridamole50–53
or dobutamine54–61 has also been proposed for risk stratifica-
tion. Pharmacological stress echocardiography has proven to
be a safe and sensitive technique for predicting perioperative
cardiac events, with an excellent negative predictive power.
It is still uncertain, however, which of these tests shows
the best prognostic accuracy. Limited data are available
directly comparing the performance of these tests. In
addition, variability in the pretest probability of coronary
artery disease, the mixture of surgical procedures, and
differences in criteria for positivity have made it difficult to
compare the performance of the tests directly.
Our aim in this study was to evaluate the comparative
performance of these six diagnostic tests under conditions
which adjusted for variations in preoperative risk and
diagnostic thresholds, using a meta-analytic design.
METHODS
Data extraction
An electronic search of published reports was undertaken to
identify studies published between January 1975 and April
2001 in English language journals. A computer generated
Medline search was applied, using the terms ‘‘cardiac
evaluation’’, ‘‘cardiac risk’’, ‘‘perioperative myocardial ischae-
mia’’, ‘‘perioperative cardiac morbidity’’, ‘‘myocardial infarc-
tion’’, ‘‘perioperative outcome predictors’’, and ‘‘major
vascular surgery’’, in conjunction with one of the following
non-invasive tests used for detection of myocardial ischae-
mia: ‘‘exercise electrocardiography’’, ‘‘continuous ambulatory
electrocardiography monitoring’’, ‘‘radionuclide ventriculo-
graphy’’, ‘‘dobutamine and dipyridamole stress echocardio-
graphy’’, and ‘‘myocardial perfusion scintigraphy’’.
Additional references were obtained from the bibliographies
of review articles and original papers.
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Studies were included if perioperative (30 day) data on
cardiac death and non-fatal myocardial infarction or the
composite were reported, and if the absolute numbers of true
positive, false negative, true negative, and false positive
observations were available (including positivity thresholds),
or were derivable from the data presented. If several studies
were done on overlapping patient populations then one
report was selected which had the largest sample size. If
several tests were studied simultaneously, data from each
were extracted separately. Studies in which preoperative
coronary revascularisation occurred as a result of a positive
test result were only included if patients who underwent
such procedures could be excluded or analysed separately.
Pertinent data from the selected studies were extracted
independently by two of us (MDK and EB), using standar-
dised spreadsheets. Discrepancies were resolved by consen-
sus. Information extracted included reference data (first
author, journal, institution), publication year, number of
patients, mean age, proportion of male patients, type of
vascular surgery, percentage of patients with a history of
coronary artery disease (defined as either past or current
angina pectoris, history of myocardial infarction, or heart
failure) and diabetes mellitus, type of radionuclide used, and
the type of exercise performed or the type of pharmacological
stress agent used. Criteria for positivity were recorded. This
information is shown in table 1.
Data analysis
One hundred and thirty one studies published between
January 1975 and April 2001 were screened. Fifty eight met
the inclusion criteria (table 2). Data on some explanatory
variables were not specified in the studies included. In seven
studies14 15 18 22 37–39 the mean age was absent; in
six14 15 24 36 37 42 the sex distribution was absent; in three10 13 14
the proportion of patients with a history of coronary artery
disease was not specified; and in 207 10 13–16 20–23 25–31 35 37 40 the
proportion of patients with diabetes was not given. Estimates
for these variables were used, based on a best subset
regression analysis, so that the maximum number of selected
studies could be included. Weighted mean values for the
missing data using sensitivity analysis or excluding studies
from the analysis did not alter the results. Therefore, all
selected studies were included for analyses.
Differences in baseline clinical characteristics between the
study populations were evaluated using x2 statistics. To
account for a possible source of heterogeneity in diagnostic
threshold between studies, pooled results weighted by the
sample size of each study were calculated using a random
effect model, based on a single treatment effect and standard
error for each of a set of studies.62 Results are presented as
percentage sensitivity and specificity with 95% confidence
intervals (CI).
Summary receiver operating characteristic (SROC) curves
were generated to describe diagnostic performance over a
range of threshold values for each non-invasive test (see the
appendix). Univariable and multivariable regression analyses
were undertaken to study the influence of clinical and study
characteristics on test performance, including the number of
patients tested and operated on, the mean age of the patients,
the proportion of men, the proportion of patients with a
history of coronary artery disease, the proportion of patients
with diabetes mellitus, and the year of publication.
Comparisons using SROC analysis were also undertaken to
enable us to study diagnostic performance between separate
tests. In each case we included all significant explanatory
variables, along with the variable indicating the test
comparison. We developed models with identical explanatory
variables across all comparisons. The differences in diagnostic
performance between separate tests are represented by the
relative diagnostic odds ratios with 95% CI. The relative
diagnostic odds ratio indicates the diagnostic performance of
a test, with a value larger than 1 indicating better
discriminatory power, a value equal to 1 indicating no
difference, and values below 1 indicating reduced discrimi-
natory ability. In order to adjust for the fact that multiple
comparisons were made, a probability value of p (0.01 was
considered significant. All statistical analyses were done
using ‘‘meta’’ and ‘‘metareg’’ commands for STATA 6.0 for
Windows (STATA Corporation, Texas, USA).
RESULTS
Clinical and study characteristics
A summary of the clinical characteristics of the studies
included in the meta-analysis is given in table 3. Mean age
was similar between the studies. The majority of patients in
the studies were male, with no significant difference between
the studies (p = 0.380). Coronary artery disease was more
common in patients who underwent radionuclide ventricu-
lography, ambulatory ECG, and myocardial perfusion scinti-
graphy (p = 0.03) compared with the other tests. The
prevalence of diabetes was less than that of coronary artery
disease, with no significant difference between the studies
(p = 0.06). Vascular surgery was not cancelled because of a
positive test result after ambulatory ECG, radionuclide
ventriculography, or dobutamine stress echocardiography.
Preoperative revascularisation was undertaken following a
positive test result in 16 patients who underwent exercise
ECG, in 70 who underwent myocardial perfusion scintigra-
phy, and in 12 who underwent dipyridamole stress echo-
cardiography. Patients undergoing preoperative coronary
revascularisation were excluded or analysed separately in
these studies. No operations were cancelled as a result of any
exercise ECG abnormalities, but in 36 cases the operation was
cancelled after a positive test result during myocardial
perfusion scintigraphy.
Weighted pooled results
The diagnostic test performance for individual studies is
outlined in table 3. In pooled data weighted by the number of
patients with and without disease in each study, dobutamine
stress echocardiography showed the highest sensitivity (true
positive ratio) of 85% (95% CI 74% to 97%) with a specificity
(1 2 false positive ratio) of 70% (95% CI 62% to 79%)
compared with the other tests (table 3).
Summary receiver operation characteristic analysis
for each diagnostic test
In a univariable analysis for ambulatory ECG, none of the
selected clinical risk factors was a significant predictor of the
Table 1 Test positivity criteria used for each non-
invasive preoperative test
Non-invasive test Positivity criterion
Ambulatory ECG ST segment depression of >1 mm or ST
elevation >2 mm after J point (measured at
60 ms) lasting at least one minute
Exercise ECG Development of exercise induced horizontal
or downsloping ST depression of 1 mm or
more
Radionuclide
ventriculography
Ejection fraction (35%
Myocardial perfusion
scintigraphy
One or more fixed or reversible thallium-201
myocardial defects
Dipyridamole stress
echocardiography
New or worsening ventricular wall motion
abnormalities
Dobutamine stress
echocardiography
New or worsening ventricular wall motion
abnormalities
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performance of the test. In fig 1, the SROC curve describes
the test characteristics of ambulatory ECG monitoring in the
studies included. When the selected clinical risk factors and
study characteristics were tested in univariable analyses,
none of the characteristics changed the SROC curve
substantially. This was also observed when the performance
of exercise ECG and dobutamine stress echocardiography was
tested in separate univariable analyses—again analyses of
exercise ECG and dobutamine stress echocardiography
showed that none of the clinical and study characteristics
changed the SROC curves (fig 1). Unlike the above described
non-invasive tests, separate univariable SROC analyses for
radionuclide ventriculography and myocardial perfusion
scintigraphy showed that among the clinical risk factors
and study characteristics only publication year changed the
SROC curves significantly. The performance of the tests
diminished with a later year of publication (fig 1).
Remarkably, the estimates of sensitivity (true positive rates)
and 1 2 specificity (false positive rates) for dipyridamole
stress echocardiography were inversely correlated when
individual studies were plotted (fig 1). In this case only
pooled sensitivity and specificity could be calculated. Thus
the SROC analysis was not done and an SROC curve for
dipyridamole stress echocardiography was not constructed.
Comparison of diagnostic tests
Table 4 shows the results of the comparison of SROC analyses
with (table 4B) and without (table 4A) adjustment for
publication year. In the present study only publication year
was a significant predictor of test performance for some of
the tests analysed (radionuclide ventriculography and myo-
cardial perfusion scintigraphy). In order to compare differ-
ences in diagnostic performance between the studies, the
variable ‘‘publication year’’ was also included in all compar-
isons.
Ambulatory ECG performed no better than exercise ECG or
myocardial perfusion imaging. Although there was a trend
for ambulatory ECG to have a lower predictive performance
than radionuclide ventriculography (p = 0.04) or dobuta-
mine stress echocardiography (p = 0.03), this did not reach
significance in univariable analysis and after correcting for
publication year. Indeed, after adjustment for publication
year an inverse relation was observed between radionuclide
ventriculography and ambulatory ECG, though this was not
significant. Exercise ECG showed a trend for a better
discriminative power than ambulatory ECG and myocardial
perfusion scintigraphy, and a reduced discriminative ability
compared with radionuclide ventriculography and dobuta-
mine stress echocardiography. However, these differences
were non-significant (table 4). Myocardial perfusion scinti-
graphy showed lower discriminatory ability than ambulatory
ECG, exercise ECG, or radionuclide ventriculography, though
the differences were also non-significant. However, myocar-
dial perfusion scintigraphy had a substantially lower dis-
criminatory power than dobutamine stress echocardiography
(p = 0.001), and this difference remained significant after
adjusting for publication year (p = 0.002). Finally, dobuta-
mine stress echocardiography showed a positive trend
towards a better diagnostic performance than all the other
tests, but this only reached significance in comparison with
myocardial perfusion scintigraphy.
DISCUSSION
Our report is a meta-analysis of contemporary papers on six
non-invasive tests used for preoperative risk stratification in
patients selected for vascular surgery. We used an innovative
meta-analytic method to estimate the diagnostic accuracy of
these tests from multiple studies. The accuracy of the tests is
presented and compared using a summary ROC curve, and
R
ef
er
en
ce
M
ea
n
a
g
e
(y
ea
rs
)
M
a
le
(%
)
C
A
D
(%
)
D
M
(%
)
Is
ot
op
e
us
ed
Te
st
us
ed
Po
si
tiv
ity
cr
ite
ri
on
Pr
eo
p
re
va
sc
ul
a
ri
sa
tio
n
(%
)
O
p
ca
nc
el
le
d
(%
)
TP
FN
TN
FP
H
ua
ng
4
8
6
8
8
9
1
2
2
7
T2
0
1
SP
EC
T
Fi
xe
d
or
re
ve
rs
ib
le
pe
rf
us
io
n
de
fe
ct
0
0
5
0
2
4
7
5
de
V
ir
gi
lio
4
9
6
5
9
6
2
6
3
3
T2
0
1
Pl
an
ar
Fi
xe
d
or
re
ve
rs
ib
le
pe
rf
us
io
n
de
fe
ct
4
0
2
0
2
7
3
0
de
V
ir
gi
lio
5
0
6
5
7
8
2
9
7
4
T2
0
1
/T
c9
9
m
SP
EC
T
Fi
xe
d
or
re
ve
rs
ib
le
pe
rf
us
io
n
de
fe
ct
0
0
3
1
3
5
4
1
D
ip
yr
id
a
m
ol
e
st
re
ss
ec
ho
ca
rd
io
g
ra
p
hy
Ti
sc
hl
er
5
1
6
8
6
1
3
4
2
9
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
4
0
1
0
0
5
Pa
sq
ue
t5
2
6
7
8
4
1
9
1
7
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
9
0
2
3
9
9
2
5
Ro
ss
i5
3
6
6
8
0
3
9
7
6
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
4
3
7
4
2
2
Si
ca
ri
5
4
6
6
8
8
2
0
1
1
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
1
5
2
4
1
9
7
3
D
ob
ut
a
m
in
e
st
re
ss
ec
ho
ca
rd
io
g
ra
p
hy
La
lk
a5
5
6
4
7
8
3
0
1
8
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
8
1
2
1
3
0
D
av
ila
-R
om
an
5
6
6
7
7
3
6
3
1
9
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
1
4
0
2
0
6
8
8
La
ng
an
5
7
6
9
8
4
3
1
1
0
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
5
6
3
0
3
1
4
0
Po
ld
er
m
an
s5
8
6
8
8
9
3
1
1
2
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
5
0
9
6
3
0
Ei
ch
el
be
rg
er
5
9
6
8
6
0
3
7
2
9
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
2
0
4
8
2
5
Po
ld
er
m
an
s6
0
6
7
8
5
3
1
1
1
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
1
7
0
2
2
8
5
5
Sh
af
ri
tz
6
1
6
6
6
4
3
3
1
7
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
1
0
3
0
1
1
Bo
er
sm
a6
2
6
9
7
8
4
3
1
5
N
A
N
A
N
ew
or
w
or
se
ni
ng
RW
M
A
du
ri
ng
te
st
0
0
2
9
1
4
8
6
3
1
8
7
C
A
D
,
co
ro
na
ry
ar
te
ry
di
se
as
e;
D
M
,
di
ab
et
es
m
el
lit
us
;
EF
,
ej
ec
tio
n
fr
ac
tio
n;
FN
,
fa
ls
e
ne
ga
tiv
e;
FP
,
fa
ls
e
po
si
tiv
e;
N
A
,
no
ta
pp
lic
ab
le
;
O
p,
op
er
at
io
n;
Pr
eo
p,
pr
eo
pe
ra
tiv
e;
RW
M
A
,
re
st
in
g
w
al
lm
ot
io
n
ab
no
rm
al
ity
;
TN
,
tr
ue
ne
ga
tiv
e;
TP
,
tr
ue
po
si
tiv
e;
-,
m
is
si
ng
va
lu
es
.
Ta
b
le
2
C
on
tin
ue
d
1330 Kertai, Boersma, Bax, et al
www.heartjnl.com
 on 7 November 2006 heart.bmjjournals.comDownloaded from 
Table 3 Summary of clinical characteristics and sensitivity and specificity of the studies included in the meta-analysis
Type of test
No. of
studies
No. of
patients
Mean age
(years)
Proportion of
men (%)
History of
CAD (%)
Proportion of
DM (%)
Sensitivity
(%; 95% CI)
Specificity
(%; 95% CI)
Radionuclide ventriculography 8 532 67.0 83 45 25 50 (32 to 69) 91 (87 to 96)
Ambulatory electrocardiography 8 893 68.0 72 55 32 52 (21 to 84) 70 (57 to 83)
Exercise electrocardiography 7 685 64.5 72 36 28 74 (60 to 88) 69 (60 to 78)
Dipyridamole stress echocardiography 4 850 66.8 78 28 33 74 (53 to 94) 86 (80 to 93)
Myocardial perfusion scintigraphy 23 3119 65.5 78 40 30 83 (77 to 89) 49 (41 to 57)
Dobutamine stress echocardiography 8 1877 67.3 76 37 16 85 (74 to 97) 70 (62 to 79)
Tests are sorted according to ascending sensitivities.
CAD, coronary artery disease; CI, confidence interval; DM, diabetes mellitus.
Table 4 Results of the comparison of summary receiver operating characteristic analyses between diagnostic tests
Reference test
Ambulatory
electrocardiography
Exercise
electrocardiography
Radionuclide
ventriculography
Myocardial
perfusion
scintigraphy
Dobutamine stress
echocardiography
(A) Not adjusted for publication year
Ambulatory electrocardiography 0.6 (0.2 to 1.8) 0.2 (0.0 to 1.0) 1.6 (0.5 to 5.0) 0.3 (0.1 to 1.0)
Exercise electrocardiography 1.6 (0.5 to 24.5) 0.5 (0.0 to 6.1) 2.7 (0.3 to 8.2) 0.6 (0.2 to 1.8)
Radionuclide ventriculography 5.5 (1.1 to 24.5) 2.2 (0.2 to 30.0) 5.5 (0.8 to 36.6) 0.9 (0.1 to 18.2)
Myocardial perfusion scintigraphy 0.6 (0.2 to 1.8) 0.4 (0.1 to 30.0) 0.2 (0.0 to 1.2) 0.3 (0.1 to 0.6)
Dobutamine stress echocardiography 3.0 (1.2 to 7.4) 1.6 (0.5 to 4.5) 1.1 (0.1 to 20.1) 4.1 (1.6 to 10.0)
(B) Adjusted for publication year
Ambulatory electrocardiography 0.7 (0.4 to 3.0) 1.3 (0.2 to 8.2) 1.5 (0.5 to 4.1) 0.4 (0.1 to 2.5)
Exercise electrocardiography 1.5 (0.3 to 6.7) 0.4 (0.0 to 4.1) 1.5 (0.4 to 5.5) 0.7 (0.1 to 6.7)
Radionuclide ventriculography 0.7 (0.1 to 4.5) 2.7 (0.2 to 30.0) 2.2 (0.3 to 13.5) 0.08 (0.0 to 5.5)
Myocardial perfusion scintigraphy 0.7 (0.3 to 2.0) 0.7 (0.2 to 2.5) 0.5 (0.1 to 3.0) 0.2 (0.1 to 0.5)
Dobutamine stress echocardiography 2.5 (0.4 to 16.4) 1.5 (0.2 to 14.9) 12.2 (0.2 to 897.8) 5.5 (2.0 to 14.9)
The figures indicate relative diagnostic odds ratios for comparison between the reference test in the column v the test in the row; the relative diagnostic odds ratio
indicates the diagnostic performance of a test, with a value larger than 1 indicating better discriminatory power, a value equal to 1 no difference, and values below
1 corresponding to reduced discriminatory ability. Figures in parenthesis are the 95% confidence intervals.
p,0.01.
Figure 1 Graphs showing summary receiver operating characteristic (SROC) curves for ambulatory ECG, exercise ECG, dobutamine stress
echocardiography, radionuclide ventriculography, and myocardial perfusion scintigraphy. The horizontal axis represents the false positive rate (1 2
specificity) and the vertical axis the true positive rate (sensitivity). The graph for dipyridamole stress echocardiography represents a plot of the estimates
of the true positive rate for dipyridamole stress echocardiography against the estimates of false positive rate, with a solid line representing the
regression line. In all graphs, solid circles represent studies with more than 100 patients and open circles represent studies with less than 100 patients.
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the performance of individual tests was corrected for selected
patient and study characteristics. Our results show that
pharmacological stress tests have a higher overall sensitivity
and specificity than the other tests. In particular, dobutamine
stress echocardiography showed a positive trend for better
diagnostic performance than the other tests, but this was
only significant in comparison with myocardial perfusion
scintigraphy. Ambulatory ECG, exercise ECG, and radio-
nuclide ventriculography yielded a lower sensitivity and
reasonable specificity, but no significant difference in
predictive performance.
Ambulatory ECG monitoring showed low sensitivity and
higher specificity in the present study, but no significant
difference in predictive performance. The use of ambulatory
ECG monitoring for perioperative cardiac risk assessment
was first described by Raby and colleagues.6 They reported a
sensitivity of 75% and a specificity of 83% for predicting
cardiac death and non-fatal myocardial infarction. In later
studies the predictive value of the test was corroborated, but
the sensitivity was less than reported here.9 10 Variation in
end point composition, surgical procedures, and the timing of
events could explain the observed differences in sensitivity
and specificity between studies. The advantages of the test
are that it is cheap and widely available. However, the
presence of resting ECG changes (bundle branch block, left
ventricular hypertrophy, digitalis use) may preclude reliable
ST segment analysis in 40% of patients.63 Hence, the
combination of low sensitivity and resting ECG changes
limits the application of the technique.
In our study the pooled data showed reasonable sensitivity
and specificity for exercise ECG compared with the other
tests. However, SROC analyses showed that it did not
perform better than the other non-invasive tests. This
observation may be explained by type II error—that is,
differences could be missed owing to lack of power.
Conventional exercise ECG is considered the most physiolo-
gical form of stress.64 However, the test may not always be
feasible because of exercise intolerance in such patients.
The value of radionuclide ventriculography for predicting
perioperative cardiac complications has been assessed in
many studies.20–27 A preoperatively assessed low ejection
fraction (,35%) showed a relatively poor sensitivity but a
high specificity in our meta-analysis. The SROC analysis
showed that resting left ventricular dysfunction, as deter-
mined by radionuclide ventriculography, did not have a
significantly better predictive performance than the other
tests. The observed limitation of the predictive performance
of this test may be explained by the failure to detect severe
underlying coronary artery disease, changes in predictive
value over time, and improved anaesthetic and surgical
perioperative care. Thus, radionuclide ventriculography may
not be a suitable test for preoperative risk stratification.
However, a low ejection fraction may be a useful predictor of
long term survival.64
In patients unable to perform adequate exercise (and in
most vascular surgery patients unable to exercise), a non-
exercising test is mandatory. In this regard, myocardial
perfusion scintigraphy—often combined with clinical risk
assessment—is the most extensively studied non-invasive
approach to cardiac risk stratification. In the present study a
high sensitivity but a low specificity was observed for
perioperative hard cardiac events, with a lower diagnostic
accuracy than with dobutamine stress echocardiography. The
earliest studies (between 1985 and 1987) showed that
patients with fixed or reversible scintigraphic myocardial
perfusion defects were at increased cardiac risk.28 29 However,
these results were later questioned by other investigators.38 42
The poor prognostic value observed in these studies may
reflect small sample sizes.
Comparison of myocardial perfusion scintigraphy with
stress echocardiography in our study showed that dobuta-
mine stress echocardiography performed significantly better.
There are several possible explanations for these findings.
First, myocardial perfusion scintigraphy is more widely used
in consecutive patients presenting for vascular surgery than
in selected patients with clinical risk factors; second,
unblinded test results are available to clinicians, thus
influencing perioperative care; third, repeat imaging 3–4
hours after thallium infusion may not allow sufficient time
for thallium redistribution; and finally, thallium uptake may
be uniformly restricted in patients with severe and diffuse
coronary artery disease. Nevertheless myocardial perfusion
scintigraphy is a valuable test for cardiac risk assessment,
especially in patients with contraindications to stress
echocardiography, with a reported complication rate of
3.9% in the studies included in the present meta-analysis.
However, myocardial perfusion scintigraphy should be
avoided in patients with significant bronchospasm, critical
carotid disease, or on regular theophylline treatment.64
Dipyridamole stress echocardiography has been proposed
for cardiac risk stratification in patients undergoing major
vascular surgery.50–53 The low false positive rates and
extremely high negative predictive values can make this test
a useful predictor in low risk scenarios. Indeed, in the present
meta-analysis dipyridamole stress echocardiography had a
higher specificity than myocardial perfusion scintigraphy or
dobutamine stress echocardiography. However, there have
been limited numbers of studies published to date, and in
these studies the true positive and false positive rates for
dipyridamole stress echocardiography showed a negative
correlation when they were plotted graphically. Hence
only weighted pooled sensitivity and specificity could be
calculated and the performance of the test could not be
studied in further detail. The high specificity of dipyridamole
stress echocardiography in clinical practice may indicate that
the test can identify patients at less severe ischaemic
responses. These patients may not need to undergo further
testing and can proceed to major vascular surgery directly.
However, in clinical practice it is more valuable to have a
sensitive test that can identify patients at increased risk of
perioperative cardiac events. Further conclusions about
dipyridamole stress echocardiography are limited by the
reported differences in sensitivity and specificity between the
few studies reported to date.
Dobutamine stress echocardiography showed a similar
high sensitivity, but a significantly higher specificity,
compared with myocardial perfusion scintigraphy.
Comparison using SROC analysis showed a trend towards
better performance than the other tests, but this was only
significant versus myocardial perfusion scintigraphy. As with
dipyridamole, dobutamine stress echocardiography has been
proposed for cardiac risk stratification owing to its high
negative predictive value.54–61 Moreover, in the present study
this test showed significantly higher sensitivity than dipyr-
idamole stress echocardiography. The role of dobutamine
stress echocardiography in cardiac risk stratification has been
studied extensively in recent reports.59 61 65 The results of
these studies suggest that the investigation can be done
safely and with reasonable patient tolerance and may provide
additional information about valvar dysfunction, in contrast
to myocardial perfusion scintigraphy. The test has certain
limitations—for example, it should not be used in patients
with serious arrhythmias, severe hypertension, or hypoten-
sion. However, in a recent report of the use of dobutamine
stress echocardiography in 6595 patients it was found that
the incidence of cardiac arrhythmias and hypotension was
8% and 3%, respectively, and these complications were well
tolerated and rarely required treatment.66
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Study limitations
The study has several limitations. Meta-analyses are subject
to publication bias—that is, studies with a significant result
are more likely to be submitted. Heterogeneity of study
design is another aspect that may influence the interpretation
of the results. The predictive value of a given test can be
influenced by at least two important factors: patient selection
and the blinding of test results. A test done in consecutive
patients may have a lower diagnostic accuracy than the same
test done in a selected group of patients. This is commonly
referred to as selection bias and it occurs when consecutive
cohorts of patients with a high prior probability of coronary
artery disease, and therefore of adverse cardiac outcome after
surgery, are more likely to get the test. The predictive value of
a given test may also be influenced by the availability of the
test result to the treating physicians. In this case patients
with positive test results may undergo less invasive opera-
tions or receive better perioperative care, such as cardiopro-
tective drugs, invasive haemodynamic monitoring, and
admission to an intensive care unit. Studies in which patients
are enrolled consecutively and treating physicians are blinded
to test results are more likely to provide a relatively unbiased
estimate for a given test.
Conclusions
Our meta-analysis shows that ambulatory ECG monitoring
has a relatively low sensitivity and a low specificity, with no
incremental value over the other tests. Furthermore, resting
ECG changes frequently preclude reliable assessment of the
ambulatory ECG and this test is therefore not recommended
for perioperative risk assessment. Radionuclide ventriculo-
graphy had the highest specificity but a relatively low
sensitivity, with a limited predictive performance for perio-
perative events. This test should not therefore be considered
as a tool for preoperative cardiac risk assessment. The test of
choice in most ambulatory patients is an exercise ECG done
according to the American College of Cardiology/American
Heart Association guideline.64 However, most vascular surgi-
cal candidates have important abnormalities on their resting
ECG and are unable to perform adequate exercise. In such
patients stress echocardiography or myocardial perfusion
scintigraphy should be considered. In the current study
dobutamine stress echocardiography showed a similar
sensitivity to myocardial perfusion scintigraphy but a higher
specificity and a better overall predictive performance.
Moreover, dobutamine stress echocardiography is the
favoured test if there is an additional question of valvar or
left ventricular dysfunction. Dipyridamole stress echocardio-
graphy had a lower sensitivity and a higher specificity than
myocardial perfusion scintigraphy. However, further conclu-
sions about dipyridamole stress echocardiography are limited
by the reported differences between studies and the limited
number of studies reported to date.
Meta-analysis of six non-invasive tests showed a positive
trend for dobutamine stress echocardiography to have a
better diagnostic performance than the other tests, but this
only reached significant difference in comparison with
myocardial perfusion scintigraphy.
To see the appendix, visit the Heart website—
www.heartjnl.com/supplemental
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